Author: Guler, Reto
Author: Loxton, Andre G.
Similar Items: Biomarkers and cell phenotypes in TB patients with minimal or persisting lung inflammation post-anti-TB treatment and ex-vivo atorvastatin immunomodulatory effects on M. tuberculosis-infected PBMC
- Performance of host blood transcriptomic signatures for TB diagnosis and monitoring TB treatment
- Diagnostic outcomes of CT-guided lung biopsy in an HIV and TB co-infection prevalent region
- Outcomes of patients undergoing lung resection for drug-resistant TB and the prognostic significance of pre-operative positron emission tomography/computed tomography (PET/CT) in predicting treatment failure
- Does the inclusion of the cost and burden of adverse drug reactions associated with drug-resistant TB treatment affect the incremental cost-effectiveness of new treatment regimens? A case study from the introduction of bedaquiline in South Africa National TB Programme
- Population pharmacokinetic modelling to optimise treatment for children with Rifampicin-resistant TB and HIV
- Strategies for optimising TB-HIV co-treatment in children and adolescents with drug-susceptible tuberculosis on rifampicin-based standard regimens
Similar Items: The effect of Binding Immunoglobulin Protein on the induction of regulatory B-cells during Mycobacterium tuberculosis infection
- Characterisation of the human α2(I) procollagen promoter-binding proteins
- The iron-binding proteins of iron-absorbing rat intestinal mucosa
- Investigation of regulatory B-cell responses during Mycobacterium tuberculosis exposure
- Biochemical and immunological studies of the immunoglobulin IgY
- Correlation of the Mycobacterial killing capacity of Natural killer cells with the number of activating Killer immunoglobulin-like receptors expressed on their surfaces.
- Strategies for the detection of endocrine disrupting compounds utilising recombinant oestrogen receptor ligand-binding domains and high specificity monoclonal antibodies